Nordea Investment Management AB raised its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 1.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,426,101 shares of the financial services provider's stock after purchasing an additional 80,633 shares during the period. Nordea Investment Management AB owned 0.66% of MetLife worth $355,239,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. North Capital Inc. bought a new position in MetLife during the 1st quarter worth $26,000. Motco raised its position in MetLife by 105.5% during the 1st quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after purchasing an additional 212 shares during the last quarter. GFG Capital LLC bought a new position in MetLife during the 2nd quarter worth $38,000. Abound Wealth Management raised its position in MetLife by 652.3% during the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock worth $39,000 after purchasing an additional 424 shares during the last quarter. Finally, Legend Financial Advisors Inc. bought a new position in shares of MetLife in the 2nd quarter worth about $40,000. 94.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on MET shares. Wolfe Research raised MetLife to a "strong-buy" rating in a research report on Tuesday, September 16th. Piper Sandler lowered MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price objective for the company. in a research report on Friday, September 19th. Barclays lifted their price objective on MetLife from $93.00 to $98.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. Weiss Ratings reissued a "buy (b)" rating on shares of MetLife in a research report on Wednesday, October 8th. Finally, Morgan Stanley lifted their price objective on MetLife from $94.00 to $97.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $95.18.
Read Our Latest Analysis on MET
MetLife Stock Performance
Shares of MET opened at $77.87 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a 50-day moving average of $80.15 and a 200-day moving average of $78.13. The company has a market cap of $51.79 billion, a PE ratio of 13.20, a P/E/G ratio of 0.74 and a beta of 0.86. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05.
MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business's quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.28 earnings per share. On average, equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife's dividend payout ratio (DPR) is currently 38.47%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.